News

Gadobutrol, sold by Bayer under the brand name Gadavist, became the first FDA-approved contrast agent for use in cardiac magnetic resonance imaging on July 15.

A federal judge has set a 10-month deadline, ending in May 2020, for e-cigarette and cigar makers to apply for FDA authorization to keep their products on the market.

Abbott’s fourth-generation MitraClip device was approved by the FDA July 15 to treat mitral regurgitation (MR) in a wider population of patients, the company announced this week.

After more than three decades away from the cause, Brigham and Women’s Hospital cardiologist James Muller, MD, is back to warn a younger generation of physicians about the threat and potential consequences of nuclear war, the Boston Globe reports.

Heavy air pollution in China could be contributing to a greater instance of coronary atherosclerosis among the country’s general population, according to research out of the University of Buffalo.

Edoxaban and warfarin are equally effective in reducing the risk of stroke, systemic embolic events and major bleeding in patients with atrial fibrillation and a history of liver disease, researchers reported in the Journal of the American College of Cardiology this month.

Oregon Health & Science University Hospital saw an “alarming” number of patient deaths in 2017, the year before its heart transplant program ultimately crumbled, new data has revealed.

Researchers in Italy are developing “smart,” photo-responsive materials they hope will replicate the mechanical properties of a human heart in an artificial format, Cosmos Magazine reported July 12.

The Centro Nacional de Investigaciones Cardiovasculares, a research foundation in Madrid, Spain, has coordinated the first international consensus document to streamline MRI protocol after myocardial infarction in clinical trials and experimental models.

A study published in the Journal of the American Heart Association this month identified marriage as a predictor of better short- and long-term outcomes in patients with ACS, most notably male patients.

Where are you with wearable devices? Sporting an Apple Watch or a Fitbit right now? When was the last time you looked at it? When patients ask you about a new device they saw on the internet, do you do some intel?

The Center to Advance Palliative Care suggests steps cardiologists can take to ensure ongoing identification and management of remediable sources of suffering and distress in heart failure patients.